ARO-ANG3

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of ARO-ANG3 in Adults With Mixed DyslipidemiaNCT04832971Arrowhead PharmaceuticalsPhase 2Completed2022-08-30Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.